The Effect of Curcumin on the Expression of INFγ, TNF-α, and iNOS Genes in PBMCs Infected with Leishmania major [MRHO/IR/75/ER]

Infect Disord Drug Targets. 2022;22(6):e040422203031. doi: 10.2174/1871526522666220404083220.

Abstract

Background: Leishmaniasis, caused by the Leishmania parasite, is one of the most important tropical neglected diseases. The urgent search for effective, inexpensive, and preferably herbal anti-leishmanial agents, is needed.

Objective: Curcumin is a natural polyphenolic compound derived from turmeric that is well known for its antioxidant, anti-inflammatory, anti-tumor, and anti-cancer activity.

Methods: The present work evaluates the anti-leishmanial [Leishmania major] activity of curcumin. The infected PBMCs were treated with curcumin. The ROS level at 6, 12, 24 h and gene expression levels at 24, 48, and 72 h of PBMCs after treatment with curcumin were determined.

Results: Based on the results, the curcumin concentrations of 268 μM [24 h] and 181.2 μM [72 h] were defined as IC50 against L. major promastigotes. Treatment of L. major infected-peripheral blood mononuclear cells [PBMCs] with IC50 concentrations of curcumin, depending on exposure time, significantly induced the reactive oxygen species [ROS] generation and increased the expression levels of interferongamma [IFN-γ], tumor necrosis factor-alpha [TNF-α], and nitric oxide synthase [iNOS] genes.

Conclusion: These findings suggest the potential of curcumin against Leishmaniasis.

Keywords: Curcumin; Leishmania major; PBMCs; gene expression; interferon gamma; tumor necrosis factor.

MeSH terms

  • Curcumin*
  • Humans
  • Interferon-gamma
  • Leishmania major*
  • Leishmaniasis*
  • Leukocytes, Mononuclear
  • Nitric Oxide Synthase Type II
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha

Substances

  • IFNG protein, human
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • NOS2 protein, human
  • Nitric Oxide Synthase Type II
  • Curcumin